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Activation of the immune response during injury is a
critical early event that determines whether the
outcome of tissue restoration is regeneration or
replacement of the damaged tissue with a scar. The
mechanisms by which immune signals control
these fundamentally different regenerative pathways
are largely unknown. We have demonstrated that,
during skin repair in mice, interleukin-4 receptor a
(IL-4Ra)-dependent macrophage activation con-
trolled collagen fibril assembly and that this process
was important for effective repair while having
adverse pro-fibrotic effects. We identified Relm-a
as one important player in the pathway from IL-4Ra
signaling in macrophages to the induction of lysyl
hydroxylase 2 (LH2), an enzyme that directs persis-
tent pro-fibrotic collagen cross-links, in fibroblasts.
Notably, Relm-b induced LH2 in human fibroblasts,
and expression of both factors was increased in
lipodermatosclerosis, a condition of excessive hu-
man skin fibrosis. Collectively, our findings provide
mechanistic insights into the link between type 2
immunity and initiation of pro-fibrotic pathways.
INTRODUCTION
Restoration of tissue integrity and function after injury is a funda-
mental biological process that is crucial for survival in most
organisms. However, there is vast variability between speciesand tissues in the capacity to regenerate damaged tissue
(Tanaka and Reddien, 2011). In particular, mammals are charac-
terized by limited regenerative capacity and tend to replace
injured parenchymal cells and extracellular matrix (ECM) with a
unique connective tissue defined as scar. Scar tissue is charac-
terized by structural, biochemical, and mechanical alterations
that inmost circumstances lead to loss of original tissue function.
How to avoid the detrimental process of scar formation and pro-
mote organ regeneration is still unresolved. Because there is
substantial evidence for a negative correlation between immune
competence and regenerative capacity (Eming et al., 2009;
Medzhitov et al., 2012), the immune response might offer an
important therapeutic target for manipulating the quality of the
healing response toward reduced scar formation and improved
regeneration. Yet, themechanisms by which the immune system
influences scarring versus regeneration of organ structure and
function remains largely unexplained.
In most mammalian tissues, mechanical injury induces a dy-
namic cellular program proceeding in sequential stages of tissue
growth and differentiation (Martin, 1997; Gurtner et al., 2008).
The healing response in skin after excisional injury is initiated
by a local inflammatory response, followed by the formation of
vascularized granulation tissue characterized by myofibroblast
differentiation and deposition of provisional ECM that ultimately
converts into a persistent fibrous scar tissue. Repair of the
dermal tissue is paralleled by regeneration of the overlying
epidermis, leading to wound closure.
The type-2-cell-mediated immune response has been identi-
fied as a key regulator of progressive fibrosis due to tissue dam-
age in diverse pathological conditions, including chronic asthma,
liver fibrosis, and scleroderma (Wynn and Ramalingam, 2012).
Type-2-cell-associated immune responses are characterized
by the production of interleukin-4 (IL-4) and IL-13, as well asImmunity 43, 803–816, October 20, 2015 ª2015 Elsevier Inc. 803
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many other T helper 2 (Th2)-cell-associated cytokines, and phys-
iologically have been implicated in important host protective re-
sponses, e.g., against helminths (Allen and Maizels, 2011; Chen
et al., 2012; Wynn and Ramalingam, 2012; Gause et al., 2013).
Helminths, trafficking through host tissues, can cause extensive
damage, and from an evolutionary perspective, it has been
postulated that the type-2-cell-mediated immune response
evolved to facilitate localized restoration of tissue integrity by
rapid repair of damaged tissue (Gause et al., 2013). The type-
2-cell-mediated immune responses might therefore have a
dual role in host protection, including parasite destruction by
encapsulation as well as rapid restoration of tissue integrity.
The anti-parasitic and wound-healing responses simultaneously
produce fibrous matrix and induce scar formation, particularly in
those tissues with little regenerative capacity.
Alternative macrophage activation via the IL-4Ra has been
proposed as a means by which IL-4 and/or IL-13 mediates tis-
sue fibrosis (Gordon, 2003; Wynn, 2004; Wynn and Ramalin-
gam, 2012; Van Dyken and Locksley, 2013), but the detailed
mechanisms are unknown. Here, we have shown in a mouse
model of excisional skin injury that macrophages alternatively
activated via Relm-a production orchestrate pro-fibrotic dihy-
droxy lysinonorleucine (DHLNL)-collagen crosslinking. This
IL-4Ra-dependent pathway is critical for the formation of func-
tional granulation tissue but also for its transformation into a
persistent scar.
RESULTS
IL-4Ra Signaling in Macrophages Is Critical for
Skin-Wound Healing
To investigate the role of IL-4 and IL-13 in skin repair, full-
thickness-excision skin wounds were inflicted on the backs
of control mice (Il4rafl/ or Il4rafl/fl) and mice with complete
(Il4ra/) or myeloid-cell-restricted gene deletion (Il4rafl/Lyz2-
cre). Signaling for both cytokines is dependent upon the IL-
4Ra receptor chain. To characterize the functional impact of
IL-4 and IL-13 during the entire time course of the healing
response, we performed wound-tissue analysis during the early
(4 days post injury [dpi]), middle (7 dpi), and late phases (14 dpi)
of repair.
First, we analyzed expression of IL-4Ra in wound tissues
during the entire time course of the healing response. Double
stainings of wound-tissue sections for IL-4Ra and F4/80 (macro-
phages), CD31 (vascular cells), or aSMA (myofibroblasts) identi-Figure 1. IL-4Ra Signaling in Macrophages Is Critical for Skin-Wound
(A) IHC double staining on wound sections at 7 dpi; (left) scale bar represents 50
(B) Scheme illustrating histology of excisional skin wound.
(C) Quantification of double-positive cells in wound tissue in control mice (n = 4–
(D) Il4ra gene expression of flow-cytometry-sorted CD11b+F4/80+ wound mac
time point).
(E) Representative H&E staining of granulation tissue at 7 dpi; scale bar represen
(F) Quantification of hemorrhages in the granulation tissue and morphometric an
7 dpi) and scar (14 dpi) formation at indicated dpi (n = 14–23 wounds of 7–12 mi
(G) Flow cytometry analysis of wound cell suspensions; frequency and absolute n
(H) Frequency of BrdU+F4/80+ wound macrophages at 4 dpi, based on flow c
proliferative epithelium; pc, panniculus carnosus; sf, subcutaneous fat tissue.
arrows indicate the tip of the epithelial tongue, and each dot represents one woun
***p < 0.001. This figure is supported by Figures S1–S3 and S6.fied macrophages and myofibroblasts as the major cell popula-
tions expressing IL-4Ra during skin repair (Figures 1A–1C).
To examine whether IL-4Ra was expressed in macrophages
infiltrating the wound site, we sorted single cell suspensions of
CD11b+F4/80+ cells by flow cytometry from wound tissue of
control mice and subjected them to gene-expression analysis
by qRT-PCR (Figure S1A). Blood monocytes recruited to the
site of skin injury showed a dynamic increase in Il4ra expression,
peaking with a 3.8 ± 0.6-fold increase over circulating blood
monocytes during the middle stage of repair (Figure 1D). qRT-
PCR analysis of macrophages isolated from wound tissue and
T and B cells isolated from spleen tissue in Il4rafl/Lyz2-cre
mice confirmed efficient myeloid-specific gene deletion during
the healing response (Figure 1D; Figure S1B). In addition,
disrupted IL-4 and IL-13 responsiveness in macrophages
from Il4rafl/Lyz2-cre and Il4ra/mice was confirmed with func-
tional in vitro assays of macrophage polarization (Figures S1C
and S1D).
Morphological analysis by H&E staining of wound-tissue
sections during the diverse healing stages revealed major differ-
ences in the repair response in control mice versus in IL-4Ra-de-
ficient mice. Whereas control mice developed a vascularized
and cellular granulation tissue by 7 dpi, in mice with complete
or myeloid-cell-restricted Il4ra gene deletion, the granulation tis-
sue was highly hemorrhagic (4.3 ± 1.5-fold and 3.7 ± 1.5-fold in-
crease of area covered by erythrocytes in Il4rafl/Lyz2-cre and
Il4ra/ mice, respectively, in comparison to area covered in
controls), indicative of defective granulation-tissue formation
and a failure of the repair response (Figures 1E and 1F). Hemor-
rhages largely resolved during the time course of repair (Fig-
ure S2). The disturbed healing response in complete and
myeloid-cell-restricted IL-4Ra-deficient mice was also evident
by a transient delay in wound epithelialization at 4 dpi in these
micewhen theywere compared to controls (Figure 1F). The over-
all amount of granulation tissue was similar in wounds of control
and IL-4Ra-deficient mice (Figure 1F).
Analysis of single cell suspensions of wounded tissues by flow
cytometry revealed a reduction in the absolute and relative
numbers of macrophages (CD11b+F4/80+ cells) present during
the early and middle phases of repair in Il4rafl/Lyz2-cre mice
in comparison to those present in controls (Figure 1G). BrdU
pulse labeling of wounded mice showed that in wounds of
control mice, 6.9% ± 1.4% of macrophages proliferated during
the early stage of repair and that this process is 27.7% ±
21.5% attenuated in mutant mice, suggesting that macrophageHealing
0 mm, (right) scale bar represents 40 mm.
6 wounds of 2–4 mice per time point).
rophages at indicated dpi (n = 3–7 wounds of 3–6 mice per genotype and
ts 50 mm.
alysis of wound closure kinetics and quantification of granulation tissue (4 and
ce per genotype and time point).
umber of CD11b+F4/80+ cells at indicated dpi (n = 4–10 wounds of 4–8 mice).
ytometry analysis. d, dermis; e, epidermis; g, granulation tissue; he, hyper-
The dashed line indicates the junction between the epidermis and dermis,
d. Data are expressed as the mean and, where indicated, with ± SD. *p < 0.05;
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Figure 2. IL-4Ra Signaling in Macrophages Controls Collagen Fibril Formation and Vascular Structures
(A) (left) 3D confocal imaging analysis of IHC double staining for CD31 and Desmin on wound section at 7 dpi; networks of tube-like structures (vessels, indicated
by arrow heads) and aggregates of endothelial cells (clusters, outlined by dotted lines) in genotypes are shown as indicated. Scale bar represents 50 mm. (right)
Percentage of CD31+ structures organized in vessels or clusters within granulation tissue; n = 3 wounds of 3 mice per genotype.
(B) Quantification of Desmin+/CD31+ area at indicated dpi.
(C) qRT-PCR gene-expression analysis of Pdgfb in wound tissue in relation to unwounded skin.
(legend continued on next page)
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proliferation during skin repair is partially controlled by IL-4Ra
signaling (Figure 1H; Figure S3A). The overall cell number was
similar in wounds of control and mutant mice (Figures S3B and
S3C). There were no signs of increased bacterial infection in
mutant versus control wounds (Figures S3D–S3F).
IL-4Ra Signaling in Macrophages Controls Collagen
Fibril Formation and Vascular Structures
To investigate the molecular basis for the hemorrhagic pheno-
type in IL-4Ra-deficient mice, we assessed the formation and
structure of vascular networks within the granulation tissue by
double staining for critical components of vascular integrity (Lin-
dahl et al., 1997; Davis and Senger, 2005), including CD31, peri-
vascular cells (Desmin), and several matrix components of the
basement membrane (collagen IV, laminin 1 g chain, laminin 4
a chain). Whereas the overall quantity of CD31 staining within
the granulation tissue in wounds of control and IL-4Ra-deficient
mice at 7 dpi was comparable (Figure S3G), 3D confocal imaging
analysis revealed pronounced differences in the vascular mor-
phology. Whereas, in control mice, the formation of endothelial
tubes in network-like structures (vessels) was easily detectable
throughout the entire granulation tissue covering up to
79.8% ± 5.8% of the CD31+ area, in IL-4Ra-deficient mice,
CD31+ cells preferentially accumulated in clusters covering up
to 54.4% ± 11.3% in Il4rafl/Lyz2-cre and 44.8% ± 4.6% in
Il4ra/ mice in the granulation tissue (Figure 2A; Movies S1,
S2, and S3). In the gene-deficient mice, tube-like structures
were only occasionally detectable toward the wound edge (Fig-
ure 2A). In addition, vascular alterations inmutant micewere par-
alleled by significantly reduced association of CD31+ cells with
Desmin+ perivascular cells in mutant mice when they were
compared to controls (Figure 2B). Of note, qRT-PCR analysis
of wounded and unwounded skin in Il4rafl/Lyz2-cre and control
mice revealed a reduction of 51.3%±20.5% inPdgfb expression
in myeloid-cell-specific Il4ra mutants, a factor known to be
critical for recruitment of perivascular cells that regulate vascular
stability (Figure 2C) (Lindahl et al., 1997). Thus, the formation of
functional vascular networks was perturbed in granulation tissue
of Il4ra mutants.
The morphology of vascular alterations in mutant mice
strongly resembled the perturbed vascular phenotype recently
described in embryoid bodies generated from b1-integrin or in-
tegrin-linked kinase (ILK)-deficient endothelial cells, which re-
flects perturbed endothelial-cell-matrix interactions (Malan
et al., 2010; Malan et al., 2013). Hence, to examine whether
vascular alterations might be associated with structural matrix
defects in mutant mice, we performed ultrastructural analysis
of wound tissues. Transmission electronmicroscopy (TEM) anal-
ysis revealed profound differences between mouse strains in the
morphology of collagen fibrils in wound tissue at 7 and 14 dpi.
First, in mutant mice, collagen was less orderly and less densely
packed than in control mice (Figure 2D). Second, there was great
variability in the shape and size of fibrils in mutant mice; individ-
ual fibrils exhibited irregular outlines in cross-section, in contrast(D) Ultrastructural analysis of collagen fibrils in unwounded skin and wound gra
diameter at 7 and 14 dpi (n = 1,600 collagen fibrils in 5–7 wounds of 4–7 mice pe
(E) Tensile strength test of wound tissue at 16 dpi. Presented is the force required
as the mean and, where indicated, with ± SD; *p < 0.05; **p < 0.01; ***p < 0.001to the circular outlines in controls. In some instances, the cross-
sectional profiles of collagen fibrils reached very large diameters
up to 280–300 nm and showed irregular edges (Figure 2D,
asterisk) that were entirely absent in control mice. Third, there
was the coexistence of extremely thin collagen fibrils (Figure 2D,
arrowheads) intermingled with large ones in mutant mice,
whereas in control mice the average size was quite uniform.
Quantification of collagen fibril diameters demonstrated that
mutant mice exhibited a wider range, with profiles varying from
40–300 nm, whereas control mice contained profiles ranging
from 40–200 nm. Collagen fibril morphology was similar in un-
wounded skin of control and mutant mice. Thus, the absence
of IL-4Ra signaling in macrophages perturbed collagen fibril
formation, which might hamper proper endothelial-cell-matrix
interactions, leading to impaired vascular tube formation and,
ultimately, hemorrhages. Finally, numbers of hemosiderin-laden
macrophages (indicative of red blood cell [RBC] uptake) were
comparable in wounds of control and Il4rafl/Lyz2-cre mice,
making it unlikely that the hemorrhagic phenotype was primarily
caused by a RBC removal defect (Figure S3H).
Earlier studies have demonstrated that increased collagen I
fibril diameter is related to an enhanced tensile strength in skin
and repaired tissues (Bradshaw et al., 2003; Doillon et al.,
1988). To examine whether altered collagen fibril architecture
in IL-4Ra-deficient mice might also impact the biomechanical
properties of the scar, we determined tensile strength at
16 dpi. Notably, significantly more force (26.4% ± 14.4%) was
required to rupture scar tissue derived from mutants versus
that from controls (Figure 2E).
IL-4Ra Signaling in Macrophages Directs Plod2
Expression and Collagen Cross-Links in Skin Wounds
On the basis of the disturbed collagen fibrillogenesis, we hypoth-
esized that IL-4Ra signaling might control the structural and
biochemical assembly of the collagen matrix. We thus examined
the expression of collagen-modifying enzymes implicated in
this process. Lysyl hydroxylases (LHs, encoded by Plod genes)
are essential for hydroxylating lysine residues, a process that
directs the nature of cross-links of collagen fibers that ulti-
mately define biochemical and structural stability of collagenous
tissues (Myllyharju and Kivirikko, 2004). To examine the ex-
pression of diverse LH isoforms in skin-wound healing, we
subjected wounded and unwounded skin of Il4rafl/Lyz2-cre
and control mice to qRT-PCR analysis. Whereas wounding of
control and mutant mice did not lead to significant induction
of LH1 (Plod1) and LH3 (Plod3) expression, LH2 (long)
(Plod2) expression in control mice peaked with a 215 ± 115-
fold induction during the middle stage of repair (Figure 3A).
Notably, Plod2 expression in wounds of Il4rafl/Lyz2-cre
mice was 76.1% ± 11.5% and 47.7% ± 11.7% reduced at 7
and 14 dpi, respectively, in comparison to expression in control
mice (Figure 3A). Attenuated Plod2 expression in wounds of
Il4rafl/Lyz2-cre mice was confirmed by weak immunohisto-
chemical staining for LH2 in granulation tissue of mutant micenulation tissue at 7 dpi, scale bar represents 100 nm; quantification of fibril
r time point).
to rupture the scar tissue. Each dot represents one wound; data are expressed
.
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Figure 3. IL-4Ra Signaling in Macrophages
Directs Plod2 Expression and Collagen
Cross-Links in Wounds
(A) qRT-PCR gene-expression analysis of collagen
modifying enzymes in wound tissue in relation to
unwounded skin.
(B) IHC staining for LH2 (brown). Scale bar in-
dicates 50 mm.
(C) Quantification of LH2+ cells per high power field
(hpf) in granulation tissue at 7 dpi and unwounded
skin. d, dermis; e, epidermis; g, granulation tissue.
The dashed line indicates the junction between the
epidermis and dermis.
(D) Analysis of collagen cross-link formation in
unwounded skin and wound tissue. Each dot
represents one wound; data are expressed as the
mean. *p < 0.05; **p < 0.01; ***p < 0.001.in comparison to a strong staining signal in control mice (Figures
3B and 3C).
LH2 is the only enzyme known that hydroxylates lysine
residues specifically in the telopeptides of collagen polypep-
tides, a process that is essential to direct dihydroxy lysino-
norleucine (DHLNL) cross-links of collagen fibrils (van der Slot
et al., 2003; Pornprasertsuk et al., 2004; Pornprasertsuk et al.,
2005). DHLNL collagen cross-links are a typical feature of
mechanically stiff tissues such as bone and cartilage and are
virtually absent in human soft connective tissues such as normal808 Immunity 43, 803–816, October 20, 2015 ª2015 Elsevier Inc.skin, which is characterized by lysine-
aldehyde-derived collagen cross-links
(hydroxylysinonorleucine, HLNL) (Mylly-
harju and Kivirikko, 2004). In human
skin, identification of DHLNL collagen
cross-links has been limited to patholog-
ical conditions such as lipodermato-
sclerosis (skin fibrosis associated with
chronic venous insufficiency) or sclero-
derma (Brinckmann et al., 1999; van der
Slot et al., 2004). Here, we have
shown that in unwounded and wounded
skin of control and mutant mice, the
concentration of HLNL per collagen was
similar and not altered during the
repair response (Figure 3D). In contrast,
DHLNL collagen cross-links were de-
tected at low amounts in unwounded
skin of control mice and increased
1.9 ± 0.3-fold and 3.1 ± 0.5-fold in granu-
lation tissue 5 and 10 dpi (Figure 3D),
respectively. In mutant mice, DHLNL
cross-links were also detectable in un-
wounded skin, in comparable amounts
to those detected in controls (Figure 3D).
However, DHLNL collagen cross-links
were significantly attenuated in wound
tissue of mutant mice when compared
to that in controls (Figure 3D). Collectively,
we found that IL-4 and IL-13 responsive-
ness in macrophages controlled Plod2expression in skin wounds and determined the nature of collagen
cross-links.
Attenuated Alternative Macrophage Activation in
Late-Stage Skin-Wound Healing in Il4rafl/–Lyz2-creMice
To investigate whether impaired granulation tissue formation
and defective collagen fibrillogenesis in Il4rafl/Lyz2-cre mice is
associated with altered macrophage activation during healing
progression, CD11b+F4/80+ cells fromwound tissuewere sorted
by flow cytometry and subjected to qRT-PCR analysis. Gene
Figure 4. Relm-a Released by IL-4Ra-Regulated Alternatively Activated Macrophages Controls Plod2 Expression in Fibroblasts
(A) qRT-PCR gene-expression analysis of flow cytometry-sorted CD11b+F4/80+ wound macrophages in comparison to SSClowCD11b+ bloodmonocytes during
healing; each dot represents one wound.
(B) (left) qRT-PCR analysis of primary dermal fibroblasts (Il4ra/) co-cultured with differently activated bone-marrow-derived macrophages (Il4rafl/fl); (right) qRT-
PCR analysis of primary dermal fibroblasts (Il4rafl/fl) co-cultured with differently activated bone-marrow-derived macrophages (Il4ra/).
(C) (left) qRT-PCR analysis of bone-marrow-derived macrophages transfected with siRNA targeting or non-targeting (scrambled siRNA) Retnla mRNA; (right)
qRT-PCR analysis of fibroblasts after co-culture with bone-marrow-derived macrophages transfected with siRNA targeting or non-targeting (scrambled siRNA)
Retnla mRNA.
(D) qRT-PCR of fibroblasts stimulated with rRelm-a (1 mg/mL).
(B–D) Each dot represents one independent experiment, and each experiment was performed in triplicates. Data are expressed as mean. *p < 0.05; **p < 0.01;
***p < 0.001. This figure is supported by Figure S4.expression of wound macrophages was correlated with gene
expression in circulating blood monocytes (SSClowCD11b+)
from unwounded mice and sorted by flow cytometry. Consistent
with earlier reports from our group and others (Lucas et al., 2010;
Willenborg et al., 2012), early and late-stage wound macro-phages are characterized by a distinct gene-expression profile
reflecting classical and alternative activation during the early
and late phase of repair, respectively (Figure 4A). In control
mice, expression of genes characterizing alternative activation,
including Cd163, Retlna, Cd206, and Il10, was low during theImmunity 43, 803–816, October 20, 2015 ª2015 Elsevier Inc. 809
early stage of repair (4 dpi) and dynamically upregulated toward
14 dpi (Figure 4A). Furthermore, early stage wound macro-
phages were characterized by a 27.7 ± 18.1-fold induction of
Nos2 expression (characterizing classical activation) that
declined over the time course of healing (Figure 4A). In contrast,
in Il4rafl/Lyz2-cre mice, alternative polarization of late-stage
woundmacrophages was significantly attenuated in comparison
to polarization in control mice, whereas in early stage wound
macrophages, Nos2 expression was significantly upregulated
and prolonged in comparison to expression in controls (4 dpi,
5.1 ± 2.2-fold increase and 7 dpi, 8.1 ± 4.7-fold increase, res-
pectively, over controls). Of note, other genes characterizing
early stage classical activation, such as Il1b, Tnf, and Il6,
were not differentially expressed in control or mutant mice
(Figure S4).
Relm-a Derived from Middle- and Late-Stage-Activated
Wound Macrophages Directs Plod2 Expression in
Fibroblasts
To explore the hypothesis that defective collagen fibril cross-
linking in Il4rafl/Lyz2-cre mice is mediated by an altered
cross-talk between macrophages and fibroblasts, we used an
in vitro co-culture system, in which the cell types have no direct
contact. Plod2 expression was assessed by qRT-PCR in skin
fibroblasts after exposure to classically (IFN-g and LPS) or
alternatively (IL-4 and IL-13) activated macrophages. Plod2
expression in fibroblasts (isolated from Il4ra/ mice) was 1.4 ±
0.1-fold upregulated upon exposure to IL-4- and IL-13-activated
macrophages in comparison to expression in fibroblasts not
exposed to macrophages or exposed to macrophages cultured
in vehicle or activated with IFN-g and LPS (Figure 4B). Consis-
tently, Plod2 expression in fibroblasts was not detected when
co-cultured with IL-4- and IL-13-treated macrophages isolated
from IL-4Ra-deficient mice (Figure 4B).
We next examined candidate macrophage-derived signals
that might induce Plod2 expression in fibroblasts. Although
in vitro studies have reported that TGF-b1 can induce Plod2
expression in fibroblasts (van der Slot et al., 2005a), Tgfb1
expression was not upregulated in IL-4- and IL-13-activated
macrophages in our model (data not shown). In contrast, Retnla,
the gene encoding a small cysteine-rich secreted molecule
that is a hallmark of alternatively activated macrophages (Gor-
don, 2003) and has been associated with experimental fibrosis
(Liu et al., 2004) and pro-fibrotic conditions in human diseases
(Angelini et al., 2009; Kushiyama et al., 2013; Fang et al.,
2015), was continuously upregulated in wound macrophages
during the time course of repair (Figure 4A). Therefore, we tested
whether Relm-a released by IL-4- and IL-13-activated macro-
phages controlled Plod2 expression in fibroblasts. We first
showed that Retlna could be effectively silenced by siRNA in
macrophages, stimulated with IL-4 and IL-13, and co-cultured
with fibroblasts (Figure 4C). Notably, IL-4- and IL-13-stimulated
macrophages transfected with Relm-a siRNA failed to induce
Plod2 expression in fibroblasts, whereas control macrophages
transfected with scrambled RNA induced expression of
Plod2 in fibroblasts (Figure 4C). To corroborate the finding that
Relm-a induced Plod2 expression in fibroblasts, we exposed
fibroblasts to recombinant murine Relm-a (rRelm-a). Stimula-
tion of fibroblasts with rRelm-a induced Plod2 expression up810 Immunity 43, 803–816, October 20, 2015 ª2015 Elsevier Inc.to 1.6 ± 0.2-fold in comparison to expression in the control
(Figure 4D).
Local Application of rRelm-a Rescues Wound-Healing
Pathology and Attenuated Plod2 Expression in
Il4rafl/–Lyz2-cre Mice
We next investigated whether myeloid-cell-restricted IL-4Ra
signaling is critical for Relm-a-mediated orchestration of granu-
lation tissue formation and collagen fibril assembly. For this pur-
pose, wound tissue of Il4rafl/Lyz2-cre and control mice was
subjected to qRT-PCR analysis to quantify Retnla expression.
Whereas in control miceRetnla expression was upregulated dur-
ing the time course of healing, the expression was significantly
reduced in wounds of Il4rafl/Lyz2-cre mice at 7 and 14 dpi,
respectively (Figure 5A). Consistent with reduced Retnla expres-
sion in purified wound macrophages in Il4rafl/Lyz2 mice (Fig-
ure 4A), immunohistochemical staining of wound tissues showed
a reduced number of Relm-a+F4/80+ double-positive cells within
the granulation tissue of Il4rafl/Lyz2-cre mice in comparison to
that in control mice (Figures 5B and 5C).
To address whether local application of rRelm-a could rescue
impaired granulation tissue formation in Il4rafl/Lyz2-cre mice,
we injected the edges of wounds in Il4rafl/Lyz2-cre mice twice
(3 and 5 dpi) with rRelm-a (1 mg/wound) or vehicle, and the repair
response was assessed. H&E staining of wound-tissue sections
at 7 dpi revealed that rRelm-a treatment normalized hemor-
rhages within the granulation tissue of Il4rafl/Lyz2-cre mice
(Figures 1E and 1F, Figures 5D and 5E). The number of wound
macrophages (CD68+ cells) was comparable in granulation tis-
sue in vehicle- or rRelm-a- injected Il4rafl/Lyz2-cre mice, sug-
gesting that the resolution of the hemorrhages is not due to
increased macrophage numbers (Figure 5F).
We then tested whether the normalized wound phenotype in
rRelm-a-treated wounds in Il4rafl/Lyz2-cre mice was associ-
ated with increased local Plod2 expression. qRT-PCR analysis
of complete wound tissue revealed that, indeed, Plod2 expres-
sion was 9.7 ± 3.7-fold upregulated in comparison to expression
in vehicle-treated wounds in Il4rafl/Lyz2-cremice. In fact, Plod2
expression was restored to an amount similar to that in Il4rafl/
mice at 7 dpi (Figure 3A, Figure 5G).
The Disturbed Healing Phenotype Is Similar in
Il4rafl/–Lyz2-cre and Retnla-Deficient Mice
To substantiate a direct role of Relm-a in skin repair, we charac-
terized the wound-healing response in Retnla/ mice. Notably,
we detected intriguing parallels regarding morphological, struc-
tural, and biochemical alterations of the wound-healing
response in Retnla/ and Il4rafl/Lyz2-cre mice (Figure 6). As
such, the repair response in Retnla/ mice was characterized
by a highly hemorrhagic granulation tissue (Figures 6A and 6B),
transient delay in wound epithelialization (Figure 6C), altered as-
sembly and size of collagen fibrils (Figure 6D), reduced DHLNL
collagen cross-links (Figure 6E), 39.0% ± 30.7% reduced
expression of Plod2 (Figure 6F) and 22.4% ± 18.8% increased
tensile strength (Figure 6G). Expression of inflammatory media-
tors including Il6, Tnf, and Il1b, numbers of inflammatory cells
(F4/80+ or Gr1+), and hemosiderin laden macrophages were
comparable in wound tissue in control and Retnla/ mice (Fig-
ure S5). Collectively, these findings demonstrate a direct role of
Figure 5. Local rRelm-a Administration Rescues Wound-Healing Pathology and Plod2 Expression in Il4rafl/–Lyz2-cre
(A) qRT-PCR analysis of Retnla in wound tissue normalized to unwounded skin.
(B) F4/80 and Relm-a double immunostaining of wound section at 7 dpi. Scale bar represents 10 mm.
(C) Quantification of F4/80+Relm-a+ cells at 7 dpi.
(D–G) Wounds in Il4rafl/Lyz2-cre mice repeatedly injected with rRelm-a or vehicle, harvested at 7 dpi. (D) Representative H&E sections (scale bar represents
50 mm), (E) quantification of hemorrhages, (F) staining for CD68+ (macrophages are indicated by arrow heads; dotted lines outline hemorrhages; the dashed line
indicates the junction between the epidermis and dermis; scale bar represents 50 mm) and quantification, (G) qRT-PCR analysis of Plod2 in wound
tissue normalized to unwounded skin. he, hyperproliferative epidermis; g, granulation tissue. Each dot represents one wound and data are expressed as the
mean. **p < 0.01; ***p < 0.001.
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Figure 6. Retnla–/– Mice Show Wound-Healing Pathologies Similar to Those of Il4rafl/–Lyz2-cre Mice
(A) Representative H&E staining of granulation tissue. Scale bar represents 100 mm.
(B) Quantification of hemorrhages in the granulation tissue at 7 dpi.
(C) Morphometric analysis of wound-closure kinetics, quantification of granulation tissue (4 and 7 dpi) and scar (14 dpi) formation at indicated dpi (n = 5–8wounds
of 3–4 mice per genotype and time point).
(D) Ultrastructural analysis of collagen fibrils in unwounded skin and wound granulation tissue at 7 dpi (scale bar represents 100 nm); quantification of fibril
diameter at 7 dpi (n = 1,300 collagen fibrils in 3–5 wounds of 3–4 mice per genotype); data are expressed as the mean ± SD.
(E) Analysis of collagen cross-link formation in unwounded skin and wound tissue.
(legend continued on next page)
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Relm-a in rapid and effective restoration of tissue integrity
and support our hypothesis that impaired wound healing in
Il4rafl/Lyz2-cre mice is at least in part mediated by a reduction
of Relm-a.
To investigate whether initiation of pro-fibrotic pathways by
Relm-a might also apply to humans, we examined the effect of
rRelm-b (1 mg/mL, 24 hr), the human homolog of murine Relm-a
(Holcomb et al., 2000), on gene expression in human dermal
fibroblasts. rRelm-b induced a 30.0% ± 18.5% increased
expression of PLOD2 and 22.6% ± 15.1% increased expression
of ACTA2 (a-smooth muscle actin) (Figure 6H). In addition, we
quantified expression of RETNLB and of PLOD2 in tissue sam-
ples of lipodermatosclerosis (excessive skin fibrosis associated
with chronic venous insufficiency) and healthy human skin by
qRT-PCR analysis (Figure 6I). Indeed, expression of both genes
was 2.8 ± 2.2-fold and 4.2 ± 1.9-fold upregulated in fibrotic
skin in comparison to expression in normal skin, suggesting a
potential relevance in the pathology of this human fibrotic skin
condition.
DISCUSSION
Here, we have shown that, after mechanical skin injury, IL-4Ra
signaling coordinated the timely switch from an inflammatory to-
ward a resolution phenotype in macrophages. We found that
defective wound healing in Il4rafl/Lyz2-cre mice was primarily
due to a failure of macrophages to initiate an essential repair pro-
gram, rather than unrestrained pro-inflammatory responses as
reported in a model of excessive helminth-induced lung damage
in IL-4Ra-deficient mice (Chen et al., 2012). We further identified
Relm-a as one critical factor released by IL-4- and IL-13-stimu-
lated macrophages for a timely and effective wound-healing
response.
An unexpected and important finding of our work was that IL-4
and IL-13 signaling in wound macrophages controlled the
architecture of collagen fibrils and the biochemistry of collagen
cross-links. Our findings suggest that alterations of these matrix
properties functionally impact both the early and the late stages
of repair. Disruption during the early repair phase was evidenced
by perturbed formation of vessels causing hemorrhages during
granulation tissue development. Alterations in late-stage repair
were revealed by increased tensile strength of scar tissue.
Type-2-cell-mediated immune signals have been widely associ-
ated with altered ECM morphology and tissue fibrosis in various
experimental and human disease conditions (Wynn, 2004; Wynn
and Ramalingam, 2012; Brinckmann et al., 2005). However,
studies have focused primarily on the quantitative assessment
of the amount of collagen deposition, rather than potential
effects of type-2-cell-mediated immune signals on post-transla-
tional collagen modifications that impact matrix architecture and
function. Collagen fibril biosynthesis is a complex and multistep(F) qRT-PCR analysis of Plod2 expression in wound tissue normalized to unwou
(G) Tensile strength test of wound tissue at 16 dpi; the force required to rupture
(H) qRT-PCR analysis of human skin fibroblasts stimulated with vehicle or huma
different donors).
(I) qRT-PCR analysis of RETNLB and PLOD2 expression in skin from patients
dot represents one donor. g, granulation tissue; he, hyperproliferative epithelium
**p < 0.01. This figure is supported by Figure S5.process of fundamental importance during embryonic develop-
ment and tissue remodeling, providing structural and biochem-
ical stability and function to tissues and organs (Myllyharju and
Kivirikko, 2004). Our study in skin gives mechanistic insights
into the regulation of this process at several levels. We have
provided direct evidence that mediators released upon IL-4-
and IL-13-mediatedmacrophage activation, particularly Relm-a,
induce expression of the collagen-modifying enzyme LH2 in
fibroblasts. DHLNL collagen cross-links mediated by LH2 are
thought to be critical for the determination of the structural,
biochemical, and mechanical properties of fibrillar collagens,
and their biological significance has been demonstrated in dis-
ease processes with tissue fragility or fibrosis with altered
PLOD2 expression (Brinckmann et al., 2001; van der Slot et al.,
2003; van der Slot- Verhoeven et al., 2005b. We think that
the hemorrhagic phenotype of the early granulation tissue in
Il4rafl/Lyz2-cremice is caused by attenuatedDHLNL cross-link-
ing. Reduced DHLNL cross-links result in defective structural
and organizational stability of the ECM, which is crucial for
proper endothelial-cell-matrix interactions during the formation
of a vascular network (Davis and Senger, 2005). The reduction
of endothelial-tube-like structures and increased assembly of
endothelial cells in clusters in granulation tissue of mutant mice
resembled the perturbed formation of vascular networks that
result from disturbed endothelial-cell-matrix interactions in
b1-integrin or ILK-deficient endothelial cells (Malan et al., 2010;
Malan et al., 2013). Our findings indicate that in IL-4Ra-deficient
mice, disturbed collagen fibril architecture also leads to per-
turbed endothelial-cell fibril contacts with the consequence of
disturbed tube formation, vascular integrity, and ultimately
increased leakage. This assumption is supported in mice with
a body-wide heterozygous deficiency for LH2 and that are
characterized by severe vascular defects, decreased DHLNL
collagen cross-links, and disturbed collagen fibrillogenesis
(Hyry, 2012).
Furthermore, the diameter of collagen fibrils was severely
altered and tensile strength of scar tissue was increased in
Il4ra mutant mice. These findings are consistent with earlier
studies demonstrating that increased collagen I fiber diameter
is related to an enhanced tensile strength in skin and repaired tis-
sue (Bradshaw et al., 2003; Doillon et al., 1988). Therefore, the
higher tensile strength we observed in mutant mice is most likely
due to the increased proportion of collagen fibrils with an
increased diameter in the scar tissue. Thus, in the absence of
IL-4Ra signaling, alterations in the fibril diameter might
contribute more to tensile strength than the amount of
cross-links. Hence, at this stage we conclude that IL-4Ra con-
trols restoration of tissue architecture and its mechanical
properties.
We identified Relm-a as one critical factor by which alterna-
tively activated macrophages in mouse wounds mediate Plod2nded skin.
the scar tissue is presented.
n rRelm-b as indicated (n = 6 per condition, obtained from fibroblasts of two
with lipodermatosclerosis in comparison to expression in normal skin; each
; each dot represents one wound. Data are expressed as the mean. *p < 0.05;
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expression in fibroblasts. We therefore propose that Relm-a ini-
tiates a pathway that is involved in collagen fibrillogenesis and
cross-linking, thus determining structural and biochemical sta-
bility of the newly forming tissue. In support of this hypothesis,
hemorrhages and attenuated Plod2 expression in middle-stage
wounds of myeloid-cell-restricted IL-4Ra-deficient mice were
rescued by local application of rRelm-a. Importantly, Retnla/
mice displayed wound healing alterations very similar to those
in Il4rafl/Lyz2-cre mice. These findings strongly suggest that
attenuated Relm-a synthesis in myeloid-cell-restricted IL-4Ra-
deficient mice is responsible for attenuated Plod2 expression
in fibroblasts and eventually its sequelae of altered matrix archi-
tecture and function. In support of a pro-fibrotic role of Relm-a,
increased Retlna expression has been associated with several
fibrotic conditions and fibroplasia in experimental mousemodels
and human disease (Liu et al., 2004; Kushiyama et al., 2013). We
show here that in human skin fibroblasts, rRelm-b (the human
homolog of murine Relm-a) induces PLOD2 expression, and
even more importantly, in lipodermatosclerosis, a pronounced
skin fibrosis in patients with chronic venous insufficiency that
is associated with increased DHLNL cross-links (Brinckmann
et al., 2001), RETLNB and PLOD2 are significantly upregulated
in comparison to their presence in healthy skin. Thus, our find-
ings provide insights into mechanisms by which Relm-a controls
matrix architecture and promotes tissue fibrosis, possibly identi-
fying an important therapeutic target to treat conditions of tissue
fibrosis.
We show that, in injured mouse skin, myeloid-cell-restricted
IL-4Ra signaling controls both pathways that facilitate rapid
restoration of tissue integrity but also simultaneously leads to
scar formation. This differs from two recent studies reporting
that type-2-cell-mediated signals facilitate skeletal muscle and
liver regeneration in mice, both processes that naturally occur
without scar formation (Heredia et al., 2013; Goh et al., 2013).
In those tissues, parenchymal cells, not macrophages, appeared
to be the direct and critical targets of IL-4 during organ regener-
ation. Importantly, in contrast to skeletal muscle and the liver, the
dermal component of skin has limited regenerative capacity in
mammals, thus healing by scar formation. Altogether, these find-
ings lead to the intriguing hypothesis that type-2-cell-mediated
immune signals promote and facilitate restoration of tissue integ-
rity after injury, but in organs with limited intrinsic regenerative
capacity, such as mammalian dermis, the process also drives
cellular pathways that are critical to scar formation.
EXPERIMENTAL PROCEDURES
Animals
Myeloid-cell-specific IL-4Ra-deficient mice (Il4rafl/Lyz2-cre) and Retnla/
mice (BALB/c background, 10–12 weeks) were generated and genotyped
as previously described (Figure S6 and Supplemental References). All
procedures were approved by the North Rhine-Westphalian State Agency
for Nature, Environment, and Consumer Protection and the University of
Cologne.
Cell Culture
Primary dermal fibroblasts were isolated from the back skin of mice and from
the skin of two different human donors. Macrophages were isolated from the
peritoneal cavity by plastic adhesion or from the bone marrow (BMDM). Stim-
ulation of cells and the co-culture system are described in the Supplemental
Experimental Procedures.814 Immunity 43, 803–816, October 20, 2015 ª2015 Elsevier Inc.Relm-a Silencing by siRNA
BMDM were transfected via the Nucleofector Kit (Lonza) with either Relm-a
targeted siRNA or scrambled siRNA (Thermo Scientific Dharmacon). Details
are described in the Supplemental Experimental Procedures.
Wounding
Wounding, preparation of wound tissue for histology, and morphometric anal-
ysis was performed as described previously (Willenborg et al., 2012). For local
treatment of wounds with rRelm-a, wound edges were injected either with
rRelm-a (1 mg in 50 mL PBS) or vehicle (50 mL PBS) at 3, 4, and 5 dpi.
Lipodermatosclerosis
Human tissue samples were obtained from patients presenting with lipoder-
matosclerosis. After collection, tissues were snap-frozen in liquid nitrogen or
stored in RNAlater (Life Technologies). RNA was isolated with the Fibrous Tis-
sueMini Kit (QIAGEN). The studywas approved by the Ethics Committee of the
Medical Faculty of the University of Cologne and informed consent of patients
was received.
Immunohistochemistry
Immunohistochemical stainings (10 mm and 40 mm cryosections) were per-
formed as described previously (Willenborg et al., 2012). Confocal microscopy
for 3D imaging of the endothelial tubes and clusters was performed as
described previously (Malan et al., 2013) by performing z-stacks and subse-
quent use of 3D projection function of the LSM 510 Meta (Zeiss). Antibodies
and analysis of stained sections, Gram staining, and iron staining are
described in the Supplemental Experimental Procedures.
Electron Microscopy
Tissue was fixed and processed according to a standard protocol. After tissue
was embedded in Epon-Araldite, ultrathin sections (50–100 nm) were analyzed
via a Zeiss 902A Transmission Electron Microscope (Zeiss) and TEM Imaging
Platform iTEM Software (Soft Imaging Systems).
Flow Cytometry
Flow cytometry and cell sorting were performed as described previously (Wil-
lenborg et al., 2012). FACS analysis and cell sorting was performedwith the BD
FACS Canto II flow cytometer, the BD FACS Aria III cell sorter, and the BD
FACS Diva Software. Antibodies used are listed in the Supplemental Experi-
mental Procedures.
Real-time PCR Analysis
RNA from complete wound tissuewas isolatedwith the Fibrous TissueMini Kit,
and RNA from single cell suspensions was isolated with the RNeasy Mini or
Micro Kits (QIAGEN). Reverse transcription and qRT-PCR analysis are
described in the Supplemental Experimental Procedures.
Collagen Cross-Link Analysis
Collagen cross-link analysis was performed as previously described (Brinck-
mann et al., 2005). Tissue specimens (about 20 mg wet weight) were reduced,
denatured, and digested. Analysis was performed with an amino acid analyzer
(Biochrom 20). Details are described in the Supplemental Experimental
Procedures.
Recombinant Relm-a
Recombinant murine rRelm-a was expressed in HEK293-EBNA cells and pu-
rified from cell culture supernatant. The identity of the purified recombinant
protein was confirmed by western blot with anti Relm-a (Peprotech). Details
are described in the Supplemental Experimental Procedures.
Tensile Strength Test
Incisional wounds (length: 2 cm) were placed on the backs of mutant mice.
At 16 dpi, two identical rectangle-shaped (1 cm 3 2.5 cm) pieces of the
back skin with scar tissue located in the center were excised and stored in
isotonic NaCl solution at 20C. Thawed specimens underwent a tensile
strength test via a material testing machine (Z2.5/TN1S, Zwick). After preload-
ing (0.05 N, 0.1 mm/s), the scar tissue was stretched until failure with a cross-
head speed of 15 mm/min.
Statistical Analysis
Statistical analysis was performed with the Student’s paired or unpaired two-
tailed t test or ANOVA one-way test analysis with Dunnett’s Multiple Compar-
ison Test. In case of not assumed equal variances, a Welch correction was
performed. Data are presented as the mean and, where indicated, with ±
SD, and significance levels are indicated in each figure.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
six figures, and three movies and can be found with this article online at
http://dx.doi.org/10.1016/j.immuni.2015.09.005.
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